| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Alterations of MET Gene Copy Number and Protein Expression in Primary Non–Small-Cell Lung Cancer and Corresponding Nodal Metastases
|
Tran, Thang N.
|
|
2016
|
17 |
1 |
p. 30-38.e1
351 p.
|
artikel
|
| 2 |
Analysis of Epidermal Growth Factor Receptor Mutations in Serum Among Japanese Patients Treated With First-Line Erlotinib for Advanced Non–Small-Cell Lung Cancer
|
Nishio, Makoto
|
|
2016
|
17 |
1 |
p. 24-29.e1
267 p.
|
artikel
|
| 3 |
Comparison of Toxicity Between Intensity-Modulated Radiotherapy and 3-Dimensional Conformal Radiotherapy for Locally Advanced Non–small-cell Lung Cancer
|
Ling, Diane C.
|
|
2016
|
17 |
1 |
p. 18-23
6 p.
|
artikel
|
| 4 |
Cystic Brain Metastases Occurring in Anaplastic Lymphoma Kinase Gene Rearranged Non–Small-Cell Lung Cancer Patients Receiving Crizotinib
|
Narayanan, Vignesh
|
|
2016
|
17 |
1 |
p. 85-90
6 p.
|
artikel
|
| 5 |
Editorial Board
|
|
|
2016
|
17 |
1 |
p. A3-
1 p.
|
artikel
|
| 6 |
EGFR and KRAS Mutations in ALK-Positive Lung Adenocarcinomas: Biological and Clinical Effect
|
Sahnane, Nora
|
|
2016
|
17 |
1 |
p. 56-61
6 p.
|
artikel
|
| 7 |
Estimation of the Survival of Patients With Lung Squamous Cell Carcinoma Using Genomic Copy Number Aberrations
|
Cao, Yan
|
|
2016
|
17 |
1 |
p. 68-74.e5
7.399933E6 p.
|
artikel
|
| 8 |
Estrogen Plus Progestin and Lung Cancer: Follow-up of the Women's Health Initiative Randomized Trial
|
Chlebowski, Rowan T.
|
|
2016
|
17 |
1 |
p. 10-17.e1
161 p.
|
artikel
|
| 9 |
Gefitinib Combined With Standard Chemoradiotherapy in EGFR-Mutant Locally Advanced Non–Small-Cell Lung Cancer: The LOGIK0902/OLCSG0905 Intergroup Study Protocol
|
Hotta, Katsuyuki
|
|
2016
|
17 |
1 |
p. 75-79
5 p.
|
artikel
|
| 10 |
Incidental Diagnosis of Asymptomatic Non–Small-Cell Lung Cancer: A Registry-Based Analysis
|
Kocher, Florian
|
|
2016
|
17 |
1 |
p. 62-67.e1
609 p.
|
artikel
|
| 11 |
Pemetrexed With Platinum Combination as a Backbone for Targeted Therapy in Non–Small-Cell Lung Cancer
|
Stinchcombe, Thomas E.
|
|
2016
|
17 |
1 |
p. 1-9
9 p.
|
artikel
|
| 12 |
Pretreatment Immune Parameters Predict for Overall Survival and Toxicity in Early-Stage Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiation Therapy
|
Shaverdian, Narek
|
|
2016
|
17 |
1 |
p. 39-46
8 p.
|
artikel
|
| 13 |
Sublobar Resection for Clinical Stage IA Non–small-cell Lung Cancer in the United States
|
Speicher, Paul J.
|
|
2016
|
17 |
1 |
p. 47-55
9 p.
|
artikel
|
| 14 |
Table of Contents
|
|
|
2016
|
17 |
1 |
p. A4-A6
nvt p.
|
artikel
|
| 15 |
Treatment Rationale and Study Design for the JUNIPER Study: A Randomized Phase III Study of Abemaciclib With Best Supportive Care Versus Erlotinib With Best Supportive Care in Patients With Stage IV Non–Small-Cell Lung Cancer With a Detectable KRAS Mutation Whose Disease Has Progressed After Platinum-Based Chemotherapy
|
Goldman, Jonathan W.
|
|
2016
|
17 |
1 |
p. 80-84
5 p.
|
artikel
|
Tijdschrift beschrijving